Are you Dr. Gillespie-Twardy?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 76 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2013 Jefferson St SW
Fl 2
Roanoke, VA 24014Phone+1 540-982-0237Fax+1 540-982-2719
Summary
- Dr. Amanda Gillespie-Twardy, MD is an oncologist in Roanoke, Virginia. She is currently licensed to practice medicine in Virginia and Pennsylvania. She is affiliated with Carilion Roanoke Memorial Hospital and LewisGale Medical Center.
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2011 - 2014- UPMC Medical EducationResidency, Internal Medicine, 2007 - 2010
Virginia Commonwealth University School of MedicineClass of 2007
Certifications & Licensure
VA State Medical License 2014 - 2026
PA State Medical License 2007 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE.Jennifer R Brown, Barbara Eichhorst, Nicole Lamanna, Susan M O'Brien, Constantine S Tam
Blood. 2024-12-26 - Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment.Jennifer R Brown, Barbara Eichhorst, Peter Hillmen, Wojciech Jurczak, Maciej Kaźmierczak
Future Oncology. 2024-04-01 - Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment.Jennifer R Brown, Barbara Eichhorst, Peter Hillmen, Wojciech Jurczak, Maciej Kaźmierczak
Future Oncology. 2024-04-01
